News

Innovative antisense therapy blocking production of TGF-β2 shows promise in reducing retinal fibrosis and improving outcomes ...
Responds to Recent Public Stockholder Communications Urges Stockholders to Protect Their Investment by Voting “FOR” the ...
HO-1 inhibits the activation of the TGF-ß/Smad3 pathway in NAFLD-related ... commentaries on rapidly progressing areas in hepatology. All articles published by JCTH, both solicited and ...
Just like many of The Ordinary’s bestselling products, the growth factor 15 percent solution comes in the brand’s signature ...
Keros' cash and cash equivalents as of March 31, 2025 was $720.5 million compared to $559.9 million as of December 31, 2024.
Normally, TGF-Beta soothes the immune system ... "Checkpoint inhibitors have been game-changing for all sorts of cancers, and it's clear that even cold tumors benefit from them," Barcellos ...
Agomab Therapeutics NV (“Agomab”) today announced late-breaking interim data from the ongoing STENOVA 1 Phase 2a clinical trial for AGMB-129, an oral gastro-intestinal (GI)-restricted small molecule ...
Sperm swim faster in high temperature environments; aging ovaries slowly lose egg support. Both affect fertility differently.
Responds to Recent Public Stockholder Communications Urges Stockholders to Protect Their Investment by Voting "FOR" the Company's Highly Qualified Director Nominees LEXINGTON, Mass., May 08, 2025 ...
Gardai have issued an appeal for witnesses to a Dublin city centre hit-and-run that left a woman seriously injured. The ...